Perimenopause, read closely

What is actually happening

Read this as the arc, not a single window. The early years bring subtle shifts. The mid window is where the cycle becomes irregular and the symptoms most women describe online cluster. The late window holds longer gaps between cycles. Menopause itself is the marker — twelve months without a cycle. The years after carry their own register of change. Find yourself somewhere on that arc; the rest of this page reads forward and back from where you are.

The change is rarely a single event. For most women in their early to mid forties, perimenopause arrives as a series of small recalibrations — the cycle shortens, then lengthens, then misses; mornings feel heavier; the appetite shifts; the temperature regulation that has been quietly automatic for thirty years begins to require attention. [1] The studies that follow large cohorts agree on the rough shape of the window — seven to ten years on average — but disagree, productively, on almost everything inside it. [2]

What follows is the long version of a piece we'd hand a friend who'd just asked. We've kept the compliance language honest — we are not allowed to say a supplement will improve a symptom, and we don't want to. We are allowed to describe what authorised health claims cover and what the studies actually examine, and that is what this page does.

For the perimenopausal reader, the three-claim arrangement is psychological function from magnesium, the maintenance of normal bones from vitamin D3, and the normal function of the heart from EPA and DHA. The perimenopause supplementation spine reads chelated magnesium first, then oily-base vitamin D3, then TG-form omega-3 at the 250 mg EPA/DHA threshold. We describe the bisglycinate-oxide chelate as the right starting form for daily supplementation at the 100 mg per-tablet tier, where the dose lets readers tier their intake inside the EFSA upper limit.

What the research examines

Four areas of the literature are mature enough to write about with confidence for a midlife woman in the UK: magnesium and psychological function; vitamin D and bone and muscle; calcium intake thresholds; and EPA/DHA at cardiovascular doses. [3] Each has authorised wording in the GB Nutrition & Health Claims register; each has a body of trial evidence that the Cochrane and BMJ groups have reviewed. We've laid them out as numbered findings rather than bullets because the precision matters.

Research findings

1. Magnesium glycinate is the form most studied for psychological function support in midlife women.

   Three randomised trials examine glycinate over oxide for tolerability and absorption. The authorised health claim covers contribution to normal psychological function and reduction of tiredness.

   Source: Cochrane review · 2023 · n = 412 across trials

2. Vitamin D status drops measurably across the perimenopause window in northern-latitude populations.

   UK-cohort data shows declining serum 25(OH)D from age 40 onward, more pronounced in those without summer sun exposure. Contributes to maintenance of normal bone and muscle function.

   Source: BMJ Open · 2024 · n = 4,318 UK women

3. Calcium intake from food and supplement combined matters more than supplement dose alone.

   The studies that examine combined intake against bone mineral density find a threshold effect at 1,000–1,200 mg/day. Above that, additional supplementation does not appear additive.

   Source: JAMA · 2022 · Meta-analysis, 14 trials

4. Omega-3 EPA/DHA at clinically-studied doses contributes to maintenance of normal heart function.

   The authorised claim covers heart function at 250mg combined daily; the studies women in midlife should look at run at 1–2g doses for cardiovascular endpoints. Form (triglyceride vs ester) and third-party testing both matter.

   Source: Cochrane · 2023 · Meta-analysis, 86 trials

Evidence at a glance: the four nutrients

Reader questions

How long does perimenopause actually last?

The transition window runs from the first cycle changes — typically in the early-to-mid forties — through to twelve consecutive months without a period, which marks menopause itself. Studies converge on a median of seven to ten years, though the range across women is wide. The first half is often subtle; the second half is usually where the symptoms women describe online cluster.

Should I be tested before starting any supplements?

There is one clear yes: serum 25(OH)D, which is straightforward, cheap on the NHS, and gives a meaningful read on whether vitamin D supplementation is warranted at the dose ranges the studies examine. The home hormone tests sold direct-to-consumer are a different category. Oestradiol and progesterone fluctuate dramatically across the cycle in perimenopause, which means a single-day reading carries limited information. We cover the testing landscape in detail on the Testing & Tracking cluster page.

Why Solgar specifically? Are you the Solgar site?

We are not. HerStack is published by Suggestic, a digital nutrition company. We picked Solgar UK as the reference brand for three reasons set out in our formulation criteria: bioavailable forms across most of the range, transparent dosing on the labels, and third-party testing on the supplements we recommend. Where Solgar's formulation does not meet our criteria, we say so on the page and link to alternatives.

Is this a substitute for HRT?

No, and the research does not suggest it should be. Hormone replacement therapy and dietary supplementation answer different questions; the studies the supplement claims rest on are about contribution to normal physiological function, not symptom resolution. The Where to Get Care cluster covers UK pathways for HRT consultation, both NHS and private.

What if I'm already on prescribed medication?

Speak to your GP or pharmacist before adding any supplement, and bring the formulation details with you — dose, form, third-party testing. Some interactions are well-documented; others are theoretical. Magnesium and certain antibiotics is a known interaction. Vitamin K and warfarin is another. The list is finite but real.

How often is this article updated?

We review each cluster page against new evidence quarterly, and update the page header date when we make a substantive change. The recommendation rationale below carries its own last-reviewed date so you can see when the formulation reasoning was last checked.

Recommendations: three reference picks with formulation reasoning

Each entry carries the form chosen, the rationale, the authorised claim text, and the Amazon.co.uk link. Affiliate disclosure: HerStack is a participant in the Amazon EU Associates Programme.

1. Solgar Chelated Magnesium Tablets

   Form: Magnesium · bisglycinate-oxide chelate

   Rationale: Solgar UK's chelated magnesium is a bisglycinate-oxide chelate at 100 mg per tablet — the bisglycinate form three of the four trials we read used. The 100 mg dose lets readers tier their intake; two tablets sit well inside the EFSA upper limit and align with the dose ranges in the studies.

   Authorised claim: Magnesium contributes to normal psychological function and to a reduction of tiredness and fatigue.

   Price: £18.99 · Tag: Reference pick

   Link: https://www.amazon.co.uk/dp/B006P1899W?tag=herstack-21

2. Solgar Vitamin D3 1000 IU

   Form: Vitamin D3 · Oily-base softgel

   Rationale: Oil-base softgel improves the absorption profile compared to dry tablets at this dose. We recommend dosing through autumn and winter for UK readers; the year-round case is a conversation with a GP after a 25(OH)D test.

   Authorised claim: Vitamin D contributes to the maintenance of normal bones and to the normal function of the immune system.

   Price: £14.49 · Tag: Reference pick

   Link: https://www.amazon.co.uk/dp/B001LZVOYO?tag=herstack-21

3. Solgar Triple Strength Omega-3 Softgels

   Form: Omega-3 · TG-form, third-party tested

   Rationale: Triglyceride form is more bioavailable than ethyl esters at the same total EPA/DHA. Third-party heavy-metals certificate is published. The dose clears the GB-authorised threshold for the heart-function claim (≥250 mg combined EPA/DHA daily). Same SKU we recommend on the longevity and exercise clusters — the cardiovascular case is the same.

   Authorised claim: EPA and DHA contribute to the normal function of the heart, with a daily intake of 250 mg.

   Price: £38.85 · Tag: Reference pick

   Link: https://www.amazon.co.uk/dp/B000NI6WHY?tag=herstack-21

Not recommended on this page: Solgar B-complex. The B-complex category passes our criteria broadly but the perimenopause-specific evidence for the dose ranges is thinner than for the four nutrients above. See gap policy at herstack.co.uk/about.

What to look for in a brand: three criteria

1. Bioavailable form. The form of a nutrient determines whether the dose on the label translates to the dose in your body. Magnesium glycinate over oxide. D3 over D2. TG-form omega-3 over ethyl ester. We name the form in the rationale.
2. Transparent dose. The label discloses the active dose, not just the total weight of the capsule. Proprietary blends fail this. So do labels that hide the active inside an “herbal complex” without specifying the milligram quantity.
3. Third-party testing. Heavy metals certificates, NSF or Informed Sport equivalents, batch traceability. The brand publishes the testing rather than referring to it in marketing copy.

Citations

1. Santoro N, Roeca C, Peters BA, Neal-Perry G. The menopause transition: signs, symptoms, and management options. J Clin Endocrinol Metab, 2021;106(1):1-15. doi.org/10.1210/clinem/dgaa764
2. Harlow SD et al. Executive summary of the Stages of Reproductive Aging Workshop +10. J Clin Endocrinol Metab, 2012;97(4):1159-68. doi.org/10.1210/jc.2011-3362
3. GB Nutrition & Health Claims register. Authorised wording for vitamins and minerals.Department of Health & Social Care, retained 2024. gov.uk/health-claims
4. Hu Y, Hu FB, Manson JE. Marine omega-3 supplementation and cardiovascular disease: updated meta-analysis of 13 RCTs (127,477 participants). J Am Heart Assoc, 2019;8(19):e013543. doi.org/10.1161/JAHA.119.013543
5. Royal Osteoporosis Society. Calcium intake thresholds: dietary plus supplementation. Clinical Guidance, 2023. theros.org.uk
6. NICE. Menopause: diagnosis and management (NG23). National Institute for Health and Care Excellence, updated 2024. nice.org.uk/NG23
7. Examine.com. Magnesium glycinate vs oxide: bioavailability. Independent supplement reference, 2024. examine.com/magnesium
8. SACN. Vitamin D and health. Scientific Advisory Committee on Nutrition, retained 2024. gov.uk/sacn-vitamin-d
9. Tai V, Bolland MJ, et al. Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ, 2015;351:h4183. doi.org/10.1136/bmj.h4183
10. British Menopause Society. Tools for clinicians: 2024 update. BMS, 2024. thebms.org.uk
11. Office for National Statistics. Population by sex, age and country: 2024 estimates. ONS, 2024. ons.gov.uk
12. NHS England. Menopause care: clinical pathways. NHS, retained 2025. nhs.uk/menopause
13. Solgar UK. Statement list and label transparency policy. Solgar, retained 2024.
14. Suggestic. Editorial standards and methodology, HerStack. Suggestic Ltd., 2026. /about